- Home
- PINE vs IKT Comparison
PINE vs IKT Comparison
Compare PINE & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PINE | IKT |
|---|---|---|
| Founded | 2019 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 241.4M | 201.3M |
| IPO Year | 2019 | 2020 |
Fundamental Metrics
Financial Performance| Metric | PINE | IKT |
|---|---|---|
| Price | $17.56 | $1.68 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $17.67 | $6.00 |
| AVG Volume (30 Days) | 163.3K | ★ 647.5K |
| Earning Date | 02-05-2026 | 11-14-2025 |
| Dividend Yield | ★ 6.50% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $57,423,000.00 | N/A |
| Revenue This Year | $14.13 | N/A |
| Revenue Next Year | $2.05 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 14.81 | N/A |
| 52 Week Low | $13.10 | $1.33 |
| 52 Week High | $17.88 | $3.32 |
Technical Indicators
Market Signals| Indicator | PINE | IKT |
|---|---|---|
| Relative Strength Index (RSI) | 66.29 | 46.51 |
| Support Level | $16.73 | $1.63 |
| Resistance Level | $17.32 | $1.73 |
| Average True Range (ATR) | 0.34 | 0.14 |
| MACD | 0.05 | -0.04 |
| Stochastic Oscillator | 94.47 | 8.50 |
Price Performance
Historical ComparisonAbout PINE Alpine Income Property Trust Inc.
Alpine Income Property Trust Inc is a real estate investment trust (REIT) that owns and operates a high-quality portfolio of commercial net lease properties in the United States. The company's portfolio predominantly comprises single-tenant retail properties located in or near metropolitan statistical areas, or MSAs. It operates in two business segments: income properties, which derive maximum revenue, and commercial loans and investments.
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.